Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × sargramostim × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 5 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Interventions

entrectinib 2 Magnetic Resonance Spectroscopy 2 tremelimumab 1 trametinib 1 selpercatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 dabrafenib 1 cobimetinib 1 X-Rays 1 Vemurafenib 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Specimen Handling 1 Mitoxantrone 1 Iodine-131 1 High-Energy Shock Waves 1 Glycoprotein Hormones, alpha Subunit 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡